Bank of New York Mellon’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-26,311
| Closed | -$8.58K | – | 4415 |
|
2023
Q2 | $8.58K | Sell |
26,311
-10,251
| -28% | -$3.34K | ﹤0.01% | 4339 |
|
2023
Q1 | $15.7K | Sell |
36,562
-100
| -0.3% | -$43 | ﹤0.01% | 4325 |
|
2022
Q4 | $19.4K | Sell |
36,662
-81
| -0.2% | -$43 | ﹤0.01% | 4360 |
|
2022
Q3 | $27K | Buy |
36,743
+100
| +0.3% | +$73 | ﹤0.01% | 4408 |
|
2022
Q2 | $42K | Sell |
36,643
-70
| -0.2% | -$80 | ﹤0.01% | 4383 |
|
2022
Q1 | $75K | Hold |
36,713
| – | – | ﹤0.01% | 4457 |
|
2021
Q4 | $106K | Hold |
36,713
| – | – | ﹤0.01% | 4393 |
|
2021
Q3 | $156K | Buy |
36,713
+17,056
| +87% | +$72.5K | ﹤0.01% | 4249 |
|
2021
Q2 | $104K | Sell |
19,657
-1,895
| -9% | -$10K | ﹤0.01% | 4207 |
|
2021
Q1 | $100K | Sell |
21,552
-1,902
| -8% | -$8.83K | ﹤0.01% | 4163 |
|
2020
Q4 | $77K | Buy |
23,454
+13,288
| +131% | +$43.6K | ﹤0.01% | 4110 |
|
2020
Q3 | $34K | Buy |
10,166
+1
| +0% | +$3 | ﹤0.01% | 4055 |
|
2020
Q2 | $34K | Sell |
10,165
-53,290
| -84% | -$178K | ﹤0.01% | 4020 |
|
2020
Q1 | $243K | Sell |
63,455
-4,546
| -7% | -$17.4K | ﹤0.01% | 3674 |
|
2019
Q4 | $411K | Buy |
68,001
+6,544
| +11% | +$39.6K | ﹤0.01% | 3684 |
|
2019
Q3 | $464K | Buy |
61,457
+3,159
| +5% | +$23.9K | ﹤0.01% | 3573 |
|
2019
Q2 | $789K | Buy |
+58,298
| New | +$789K | ﹤0.01% | 3358 |
|
2018
Q2 | – | Sell |
-33,319
| Closed | -$290K | – | 4314 |
|
2018
Q1 | $290K | Buy |
33,319
+1,504
| +5% | +$13.1K | ﹤0.01% | 3800 |
|
2017
Q4 | $398K | Sell |
31,815
-4,251
| -12% | -$53.2K | ﹤0.01% | 3695 |
|
2017
Q3 | $301K | Buy |
36,066
+537
| +2% | +$4.48K | ﹤0.01% | 3756 |
|
2017
Q2 | $602K | Buy |
35,529
+23,364
| +192% | +$396K | ﹤0.01% | 3516 |
|
2017
Q1 | $245K | Buy |
12,165
+635
| +6% | +$12.8K | ﹤0.01% | 3809 |
|
2016
Q4 | $180K | Buy |
+11,530
| New | +$180K | ﹤0.01% | 3919 |
|
2016
Q3 | – | Sell |
-10,129
| Closed | -$69K | – | 4321 |
|
2016
Q2 | $69K | Buy |
+10,129
| New | +$69K | ﹤0.01% | 4124 |
|